Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Zinc Supplement for Erosive Oral Lichen Planus
NCT06042010Completed
- Start
- Jan 2023
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Zinmax in oral lichen planus (OLP) (2 arms). Primary endpoints: Change in oral lesions at 12 weeks and Change in Matrix Metalloproteinase-9 level at 12 weeks. Started Jan 2023; status: completed.
02
Drugs
Zinmax
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT06042010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06042010.